<?xml version="1.0" encoding="UTF-8"?>
<ref id="B106">
 <label>106.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reynolds</surname>
    <given-names>HR</given-names>
   </name>
   <name>
    <surname>Adhikari</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Pulgarin</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Troxel</surname>
    <given-names>AB</given-names>
   </name>
   <name>
    <surname>Iturrate</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Johnson</surname>
    <given-names>SB</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Renin–angiotensin–aldosterone system inhibitors and risk of Covid-19</article-title>. 
  <source>N Engl J Med.</source> (
  <year>2020</year>) 
  <volume>382</volume>:
  <fpage>2441</fpage>–
  <lpage>8</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa2008975</pub-id>
  <?supplied-pmid 32356628?>
  <pub-id pub-id-type="pmid">32356628</pub-id>
 </mixed-citation>
</ref>
